🇫🇷 France Country × Condition
multiple myeloma Clinical Trials in France
Active clinical trials for multiple myeloma with research sites in France. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 4 // Recruiting: 4 Phases: Phase 1, Phase 2, Phase 2 // Updated: Daily
Total Trials
4
Recruiting Now
4
Country
🇫🇷 France
Active Trials in France (4)
NCT05828511 Phase 1, Phase 2
Recruiting
A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment
Enrollment
149 pts
Country
🇫🇷 France
Regeneron Pharmaceuticals
View Trial → NCT05947136
Recruiting
PASCA-MM Study. Impact of the PASCA (PArcours de Santé au Cours du CAncer) Program on Complications Associated With Multiple Myeloma and/or Its Treatments in the Context of a First Hematopoietic Stem Cell Autograft, in Adults Aged 18 to 70.
Enrollment
204 pts
Country
🇫🇷 France
Centre Leon Berard
View Trial → NCT07227311 Phase 2
Recruiting
A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Standard of Care in Participants With Relapsed-Refractory Multiple Myeloma (RRMM)
Enrollment
200 pts
Country
🇫🇷 France
GlaxoSmithKline
View Trial → NCT06789003
Recruiting
Evaluation of a PREHABilitation Protocol Using Adapted Physical Activity (APA) for Multiple Myeloma Patients Eligible for Intensive Autologous Stem Cell Transplantation Treatment
Enrollment
120 pts
Country
🇫🇷 France
Centre Hospitalier Henri Duffaut - ...
View Trial → Frequently Asked Questions
How many multiple myeloma clinical trials are active in France?
There are currently 4 active clinical trials for multiple myeloma with sites in France, of which 4 are actively recruiting patients.
How can I join a multiple myeloma clinical trial in France?
To join a multiple myeloma clinical trial in France, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in France directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are multiple myeloma trials in France?
Active multiple myeloma trials in France span Phase 1, Phase 2, Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology